Johnson & Johnson Earnings
-
Johnson & Johnson eyes US$2.5B in COVID-19 vaccine sales despite Q3 slideJohnson & Johnson said it recorded US$766 million in sales of the shot in the first nine months of 2021, and would need sales to triple in the fourth quarter to meet its target.MoneyOct 19, 2021
-
J&J expects to sell $2.5B in COVID-19 vaccines this year despite safety issuesJ&J expects to produce 500 million to 600 million doses of the vaccine this year, Chief Financial Officer Joseph Wolk said.MoneyJul 21, 2021
Trending
-
Meet the man who’s lived 30 years in Stanley Park52,024 Read
-
Woman who wheeled a corpse into bank to co-sign a loan arrested38,187 Read
-
All 787 Dreamliners should be grounded, Boeing whistleblower says32,777 Read
-
Uber driver shot, killed by 81-year-old after both received scam calls20,022 Read
-
Gas prices surge in some parts of Canada. What’s causing pain at the pumps?17,733 Read
-
Election interference worse than government admits, rights coalition says9,077 Read
-